NERV FY 2020 Earnings — Minerva Neurosciences, Inc. Revenue & Financial Results | Market Cap Arena

NERVMinerva Neurosciences, Inc.

$53M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$41M

Gross Profit

$41M100.0% margin

Operating Income

$2M4.5% margin

Net Income

$2M4.7% margin

EPS (Diluted)

$0.38

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$34M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$58M

Total Liabilities

$5M

Stockholders' Equity

$53M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41M	$0	—
Gross Profit	$41M	-$162,000	+25517.3%
Operating Income	$2M	-$76M	+102.4%
Net Income	$2M	-$72M	+102.7%